Daniel R Chard - Net Worth and Insider Trading

Daniel R Chard Net Worth

The estimated net worth of Daniel R Chard is at least $4 Million dollars as of 2024-04-26. Daniel R Chard is the Chairman & CEO of Medifast Inc and owns about 108,598 shares of Medifast Inc (MED) stock worth over $4 Million. Daniel R Chard is also the Pres Global Sales & Operations of Nu Skin Enterprises Inc and owns about 48,111 shares of Nu Skin Enterprises Inc (NUS) stock worth over $588,879. Details can be seen in Daniel R Chard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel R Chard has not made any transactions after 2022-05-05 and currently still holds the listed stock(s).

Transaction Summary of Daniel R Chard

To

Daniel R Chard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel R Chard owns 2 companies in total, including Medifast Inc (MED) , and Nu Skin Enterprises Inc (NUS) .

Click here to see the complete history of Daniel R Chard’s form 4 insider trades.

Insider Ownership Summary of Daniel R Chard

Ticker Comapny Transaction Date Type of Owner
MED Medifast Inc 2022-05-05 director & Chief Executive Officer
NUS Nu Skin Enterprises Inc 2015-07-06 President- Nu Skin Europe

Daniel R Chard Latest Holdings Summary

Daniel R Chard currently owns a total of 2 stocks. Among these stocks, Daniel R Chard owns 108,598 shares of Medifast Inc (MED) as of May 5, 2022, with a value of $4 Million and a weighting of 86.03%. Daniel R Chard also owns 48,111 shares of Nu Skin Enterprises Inc (NUS) as of July 6, 2015, with a value of $588,879 and a weighting of 13.97%.

Latest Holdings of Daniel R Chard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MED Medifast Inc 2022-05-05 108,598 33.40 3,626,630
NUS Nu Skin Enterprises Inc 2015-07-06 48,111 12.24 588,879

Holding Weightings of Daniel R Chard


Daniel R Chard Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel R Chard has made a total of 5 transactions in Medifast Inc (MED) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Medifast Inc is the acquisition of 431 shares on May 5, 2022, which cost Daniel R Chard around $78,995.

According to the SEC Form 4 filings, Daniel R Chard has made a total of 0 transactions in Nu Skin Enterprises Inc (NUS) over the past 5 years. The most-recent trade in Nu Skin Enterprises Inc is the sale of 17,500 shares on July 6, 2015, which brought Daniel R Chard around $816,725.

Insider Trading History of Daniel R Chard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel R Chard Trading Performance

GuruFocus tracks the stock performance after each of Daniel R Chard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel R Chard is -11.7%. GuruFocus also compares Daniel R Chard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel R Chard within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel R Chard's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel R Chard

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.07 -11.7 -18.62 -45.88 -6.5 17.43
Relative Return to S&P 500(%) -1.69 -8.22 -14.94 -35.43 -7.91 10.93

Daniel R Chard Ownership Network

Ownership Network List of Daniel R Chard

No Data

Ownership Network Relation of Daniel R Chard


Daniel R Chard Owned Company Details

What does Medifast Inc do?

Who are the key executives at Medifast Inc?

Daniel R Chard is the director & Chief Executive Officer of Medifast Inc. Other key executives at Medifast Inc include VP & Finance & CAO Jonathan Barrett Mackenzie , Chief Financial Officer James P. Maloney , and (Interim) CFO Joseph P Kelleman .

Medifast Inc (MED) Insider Trades Summary

Over the past 18 months, Daniel R Chard made no insider transaction in Medifast Inc (MED). Other recent insider transactions involving Medifast Inc (MED) include a net sale of 6,127 shares made by Scott Schlackman , a net sale of 35,504 shares made by Jeffrey J Brown , and a net purchase of 121 shares made by Andrea B Thomas .

In summary, during the past 3 months, insiders sold 4,053 shares of Medifast Inc (MED) in total and bought 0 shares, with a net sale of 4,053 shares. During the past 18 months, 50,182 shares of Medifast Inc (MED) were sold and 3,214 shares were bought by its insiders, resulting in a net sale of 46,968 shares.

Medifast Inc (MED)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Medifast Inc Insider Transactions

No Available Data

Daniel R Chard Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel R Chard. You might contact Daniel R Chard via mailing address: Nu Skin Enterprises, Inc., 75 West Center Street, Provo Ut 84601.

Discussions on Daniel R Chard

No discussions yet.